Partnership

We have conducted joint studies with a number of prestigious institutions in order to evaluate the effectiveness of CM-7919 and to expand our knowledge on its pharmaceutical potential.

14_partnership_edit
15_partnership_logo_01

KOREA INSTITUTE OF
RADIOLOGICAL & MEDICAL
SCIENCES

EFFICACY AND
COMBINATION WITH
RADIATION THERAPY

15_partnership_logo_02

CHA UNIVERSITY

EFFICACY TEST
IN LEUKEMIA

15_partnership_logo_03

BIOTOXTECH

TOXICITY TEST

15_partnership_logo_04

POSTECH

TetraAs STRUCTURE
ANALYSIS

15_partnership_logo_05

GYEONGSANG NATIONAL
UNIVERSITY

EFFICACY TEST,
COMBINATION THERAPY
WITH RADIATION

15_partnership_logo_06

ASAN MEDICAL CENTER

PHASE I CLINICAL
TRIAL

15_partnership_logo_07

HANDONG GLOBAL
UNIVERSITY

BASIC EFFICACY TEST

15_partnership_logo_08

INJE UNIVERSITY
COLLEGE OF MEDICINE

EFFICACY TEST,
COMBINATION THERAPY
WITH RADIATION

15_partnership_logo_09

SEOUL NATIONAL UNIVERSITY
COLLEGE OF VETENINARY
MEDICINE

STUDY ON
ANTIANGIOGENESIS
EFFECT

15_partnership_logo_10

KOREA INSTITUTE OF
SCIENCE AND TECHNOLOGY

TetraAs STRUCTURE
ANALYSIS

15_partnership_logo_11

EWHA WOMANS
UNIVERSITY

TetraAs STRUCTURE
ANALYSIS

15_partnership_logo_12

CATOLIC UNIVERSITY
OF KOREA

EFFICACY AND
COMBINATION THERAPY
WITH OTHER ANTICANCER
DRUG

15_partnership_logo_13

KOREA CANCER CENTER
HOSPITAL

EFFICACY TEST,
COMBINATION THERAPY
WITH RADIATION

CM-7919 is also known as TetraAs.

Search